Page last updated: 2024-11-02

piracetam and Multiple Sclerosis, Relapsing-Remitting

piracetam has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research Excerpts

ExcerptRelevanceReference
"To investigate the effects of levetiracetam, an antiepileptic drug, on tremor severity and related functionality in MS."9.14The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. ( D'hooghe, MB; Feys, P; Helsen, WF; Nagels, G, 2009)
"To investigate the effects of levetiracetam, an antiepileptic drug, on tremor severity and related functionality in MS."5.14The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. ( D'hooghe, MB; Feys, P; Helsen, WF; Nagels, G, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodwin, SJ1
Carpenter, AF1
Feys, P1
D'hooghe, MB1
Nagels, G1
Helsen, WF1

Trials

1 trial available for piracetam and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:3

    Topics: Administration, Oral; Adult; Anticonvulsants; Cross-Over Studies; Dose-Response Relationship, Drug;

2009

Other Studies

1 other study available for piracetam and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
Successful treatment of paroxysmal ataxia and dysarthria in multiple sclerosis with levetiracetam.
    Multiple sclerosis and related disorders, 2016, Volume: 10

    Topics: Adult; Anticonvulsants; Brain; Dysarthria; Female; Humans; Levetiracetam; Magnetic Resonance Imaging

2016